Detalles de la búsqueda
1.
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
J Thromb Haemost
; 21(3): 559-572, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36696206
2.
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
Nephrol Dial Transplant
; 27(10): 3807-15, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23114903
3.
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.
Blood Adv
; 4(13): 3085-3092, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32634236
4.
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Blood Adv
; 4(13): 3093-3101, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32634237
5.
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
BMJ
; 345: e4565, 2012 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815429
Resultados
1 -
5
de 5
1
Próxima >
>>